A pediatric high-flow nasal cannula protocol standardizes initial flow and expedites weaning

Area of Science:

• Pediatric critical care medicine
• Respiratory therapy
• Quality improvement in healthcare

Background:

• Respiratory illnesses are common admissions in pediatric intensive care units (PICUs).
• High-flow nasal cannula (HFNC) therapy is a key respiratory support method with practice variability.
• Standardizing HFNC protocols can optimize patient care and outcomes.

Purpose of the Study:

• To evaluate the impact of implementing a standardized HFNC protocol in a pediatric intensive care unit.
• To assess changes in initial flow rates, weaning efficiency, and failure rates post-protocol implementation.
• To determine the effect of the HFNC protocol on length of hospital stay.

Main Methods:

• A pre-post intervention study design was employed.
• Data collected from pediatric patients receiving HFNC therapy between January 2015 and April 2019.
• Propensity matching used to control for age and weight differences between pre- and post-protocol groups.

Main Results:

• Post-protocol patients received significantly higher initial flow (14.5 L/min vs. 10 L/min) and demonstrated a faster weaning rate (4.1 L/min/h vs. 2.4 L/min/h).
• HFNC failure rates decreased from 17% to 10% post-protocol implementation.
• The average length of hospital stay was reduced in the post-protocol group (5.97 days vs. 6.80 days).

Conclusions:

• Implementation of an HFNC protocol in pediatric care increases initial flow and accelerates weaning.
• The protocol may reduce the need for escalation to non-invasive or mechanical ventilation.
• Standardized HFNC protocols can improve clinical outcomes and resource utilization in PICUs.